Advertisement
Screener

Zosano Pharma Corp Forms 3, 4 and 5: Stock Options, 2015

Zosano Pharma Corp Forms 3, 4 and 5: Stock Options

Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 23 rows in 2015. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.

  • 2015-12-15: Reporting owner Alataris Konstantinos; Form 4/A; Security Employee Stock Option (right to buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
  • 2015-12-15: Reporting owner Alataris Konstantinos; Form 4/A; Security Employee Stock Option (right to buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
  • 2015-12-15: Reporting owner Peri Laxmi; Form 4; Security Employee Stock Option (right to buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
  • 2015-12-15: Reporting owner Peri Laxmi; Form 4; Security Employee Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
Transaction dateReporting ownerFormSecurityTransactionSharesPricePrice that dayFiling
2015-12-15Alataris Konstantinos
Officer (President)
4/AEmployee Stock Option (right to buy)
Derivative · Direct
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)−48,896
0 owned after
$8.18
exercise price
2015-12-17
2015-12-15Alataris Konstantinos
Officer (President)
4/AEmployee Stock Option (right to buy)
Derivative · Direct
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)−160,498
0 owned after
$8.18
exercise price
2015-12-17
2015-12-15Peri Laxmi
Officer (Sr. Vice President, Operations)
4Employee Stock Option (right to buy)
Derivative · Direct
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)−40,000
0 owned after
$9.29
exercise price
2015-12-16
2015-12-15Peri Laxmi
Officer (Sr. Vice President, Operations)
4Employee Stock Option (right to buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+40,000
40,000 owned after
$2.26
exercise price
2015-12-16
2015-12-15Alataris Konstantinos
Officer (President)
4Employee Stock Option (right to buy)
Derivative · Direct
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)−48,896
0 owned after
$9.29
exercise price
2015-12-16
2015-12-15Alataris Konstantinos
Officer (President)
4Employee Stock Option (right to buy)
Derivative · Direct
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)−160,498
0 owned after
$9.29
exercise price
2015-12-16
2015-12-15Alataris Konstantinos
Officer (President)
4Employee Stock Option (right to buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+209,394
209,394 owned after
$2.26
exercise price
2015-12-16
2015-09-21Alataris Konstantinos
Officer (President)
4Employee Stock Option (right to buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+48,896
48,896 owned after
$8.18
exercise price
2015-10-01
2015-09-21Alataris Konstantinos
Officer (President)
4Employee Stock Option (right to buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+160,498
209,394 owned after
$8.18
exercise price
2015-10-01
2015-05-22Peri Laxmi
Officer (Sr. Vice President, Operations)
4Employee Stock Option (right to buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+40,000
40,000 owned after
$9.29
exercise price
2015-05-27
2015-05-22Hagan Joseph P
Director
4Stock Option (right to buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+28,000
28,000 owned after
$9.29
exercise price
2015-05-27
2015-01-26
holding as of filing
XANTHOPOULOS KLEANTHIS G
Director
3Stock Option (right to buy)
Derivative · Indirect · By Xanthopoulos Family Trust
Holding$1.40
exercise price
2015-01-26
2015-01-26
holding as of filing
WILSON TROY EDWARD
Director
3Stock Option (right to buy)
Derivative · Direct
Holding$4.52
exercise price
2015-01-26
2015-01-26
holding as of filing
Tso Winnie Wing-Kei
Officer (Chief Financial Officer)
3Employee Stock Option (right to buy)
Derivative · Direct
Holding$1.28
exercise price
2015-01-26
2015-01-26
holding as of filing
Strange Alexander Ramsay
Officer (VP, Strategy & Corp. Develop.)
3Employee Stock Option (right to buy)
Derivative · Direct
Holding$1.40
exercise price
2015-01-26
2015-01-26
holding as of filing
Strange Alexander Ramsay
Officer (VP, Strategy & Corp. Develop.)
3Employee Stock Option (right to buy)
Derivative · Direct
Holding$1.40
exercise price
2015-01-26
2015-01-26
holding as of filing
Strange Alexander Ramsay
Officer (VP, Strategy & Corp. Develop.)
3Employee Stock Option (right to buy)
Derivative · Direct
Holding$1.40
exercise price
2015-01-26
2015-01-26
holding as of filing
Strange Alexander Ramsay
Officer (VP, Strategy & Corp. Develop.)
3Employee Stock Option (right to buy)
Derivative · Direct
Holding$1.40
exercise price
2015-01-26
2015-01-26
holding as of filing
Strange Alexander Ramsay
Officer (VP, Strategy & Corp. Develop.)
3Employee Stock Option (right to buy)
Derivative · Direct
Holding$1.28
exercise price
2015-01-26
2015-01-26
holding as of filing
Oza Nandan
Officer (Chief Operating Officer)
3Employee Stock Option (right to buy)
Derivative · Direct
Holding$1.40
exercise price
2015-01-26
2015-01-26
holding as of filing
Oza Nandan
Officer (Chief Operating Officer)
3Employee Stock Option (right to buy)
Derivative · Direct
Holding$1.28
exercise price
2015-01-26
2015-01-26
holding as of filing
Lamba Vikram
Director, Officer (President, CEO), 10% Owner
3Employee Stock Option (right to buy)
Derivative · Direct
Holding$1.54
exercise price
2015-01-26
2015-01-26
holding as of filing
Daddona Peter E.
Director, Officer (Chief Scientific Officer)
3Employee Stock Option (right to buy)
Derivative · Direct
Holding$1.40
exercise price
2015-01-26